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To analyze contacts made by Moloney murine leukemia virus (M-MuLV) capsid (CA) proteins in immature and mature virus
particles, we have employed a cysteine-specific crosslinking approach that permits the identification of retroviral Gag protein
interactions at particular residues. For analysis, single cysteine creation mutations were made in the context of protease-
deficient or protease-competent parental constructs. Cysteine creation mutations were chosen near the N- and C-termini of
CA and at a site adjacent to the M-MuLV Glu-Ala Fv1 N/B host range determination sequence. Analysis of immature virions
showed that PrGag proteins were crosslinked at C-terminal CA residues to form dimers while crosslinking of particle-
associated N-terminal and N/B region mutant proteins did not yield dimers, but showed evidence of linking to an unknown
140- to 160-kDa partner. Analysis of mature virions demonstrated that both N- and C-terminal CA residues participated in
dimer formation, suggesting that processed CA N- and C-termini are free to establish interprotein associations. Interestingly,
N/B region mutant residues in mature virus particles did not crosslink to form dimers, but showed a novel crosslinked band,
consistent with an interaction between the N/B tropism determining region and a cellular protein of 45–55 kDa. © 2000
Academic PressINTRODUCTION
The core (Gag) protein of the Moloney murine leuke-
mia virus (M-MuLV) is the primary determinant of virus
particle structure and expression of Gag has been
shown to be necessary and sufficient for the formation
and release of immature virus particles (Craven and
Parent, 1996). Gag is synthesized as a myristoylated
polyprotein precursor, Pr65Gag, which is cleaved by the
iral protease (PR) during or after budding to yield the
ature viral proteins matrix (MA), p12, capsid (CA), and
ucleocapsid (NC) (Barbacid et al., 1976; Bolognesi et al.,
1973; Stephenson et al., 1975). The Gag protein is deliv-
ered to the plasma membrane by an undetermined
mechanism (Swanstrom and Wills, 1997), assembles
there, and buds from the cell to yield a roughly spherical
virus particle of approximately 125 nm in diameter (Yea-
ger et al., 1998). The MA protein is myristoylated at its
N-terminus, associates with membranes, and may inter-
act with the cytoplasmic tail of the viral transmembrane
(Env) protein (Swanstrom and Wills, 1997). The role of the
p12 domain is not well understood; however, deletion of
most of the domain does not substantially affect virus
particle assembly (Barklis et al., 1997; Crawford and Goff,
1984). The NC protein specifically binds viral genomic
RNA and is required for RNA encapsidation as well as
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190serving a function in the viral assembly process (Camp-
bell and Vogt, 1995; Gorelick et al., 1988; Hansen and
Barklis, 1995). The CA domain of M-MuLV has been
shown to be important in virus particle assembly (Han-
sen et al., 1990; Jones et al., 1990; Lobel and Goff, 1984)
and budding, as well as playing a role early in infection
(Alin and Goff, 1996). Contained in the CA domain are the
major homology region (MHR), a region of 20 to 30
residues that is the only highly conserved sequence
among retroviral capsid proteins (Craven et al., 1995;
Mammano et al., 1994; Strambio-de-Castillia and Hunter,
1992), as well as the N/B locus, the determinant of
murine C-type NIH/BALB/c (N/B) cell tropism (Brown,
1997; Weiss et al., 1984).
Although it is clear that mutations in the CA domain
can affect M-MuLV particle assembly and release from
cells (Hansen et al., 1990; Jones et al., 1990; Lobel and
Goff, 1984), the exact role of the CA domain in the
assembly process remains largely unknown. Studies on
HIV-1 have shown that the carboxyl-terminus of CA is
important for virus particle assembly (McDermott et al.,
1996; Reicin et al., 1995) but much of the N-terminal
portion is dispensable for virus particle assembly
(Borsetti et al., 1998; Wang et al., 1994). In Rous sarcoma
virus, the essential assembly domains that have been
mapped lie outside the CA domain (Swanstrom and
Wills, 1997; Weldon and Wills, 1993; Wills et al., 1994).
Both the N- and the C-terminal portions of the HIV-1 CA
have been crystallized as dimers (Gamble et al., 1997;
Momany et al., 1996), and recent biophysical studies
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191MURINE LEUKEMIA VIRUS CAPSID PROTEINhave revealed some details concerning Gag–Gag inter-
actions of HIV-1 (Barklis et al., 1998; Campbell and Rein,
1999; Fuller et al., 1997; Ganser et al., 1999; Scarlata et
al., 1998), Rous sarcoma virus (Campbell and Vogt, 1995,
1997; Kovari et al., 1997), and M-MuLV (Barklis et al.,
1997; Yeager et al., 1998), but the specific residues in-
volved in interprotein contacts remain to be defined.
As a biochemical approach to examine interactions
between CA proteins in M-MuLV, we previously estab-
lished a system for cysteine crosslinking analysis of
proteins in M-MuLV virus particles (Hansen and Barklis,
1995). This system, based on the work of others (Pakula
and Simon, 1992; Pepinsky, 1983; Pepinsky et al., 1980;
Pinter and Fleissner, 1979), allows cysteine residues that
are in close proximity on adjacent proteins to be co-
valently crosslinked through the addition of cysteine-
specific chemical crosslinking reagents such as molec-
ular iodine or bis-maleimido hexane (BMH). Cysteines
located on the NC domain in immature (Hansen and
Barklis, 1995) and mature (Ott et al., 1998; Rein et al.,
996, 1997) M-MuLV particles were efficiently
rosslinked by cysteine-specific crosslinking agents. In
ddition, we found that mutation of all five cysteines
resent in M-MuLV Gag was compatible with immature
irus particle assembly, allowing us to conveniently ex-
mine the effects of cysteine creation mutations in im-
ature virions. In our current study, we also have de-
igned an efficiently processed viral construct, contain-
ng no CA or MA cysteine residues, so that CA domain
nteractions can be probed in mature virus particles.
To probe capsid domain contacts, we have made cys-
eine creation mutations in three different regions of the
-MuLV CA coding region in both protease-deficient
PR2) and protease-competent (PR1) constructs: the N-
terminal region of CA (G220C), the C-terminal region of
CA (S475C), and the N/B determining region (T323C; see
Fig. 1). We observed that in immature virus particles,
G220C proteins did not form crosslinked dimers, but
S475C proteins did. In contrast, in mature virions, both N-
and C-terminally modified proteins crosslinked efficiently
to form dimers, suggesting that during viral maturation,
the N-terminal portion of CA is reoriented so that it can
interact with neighbor molecules. Additionally, cellular
proteins of 140–160 and 45–55 kDa were identified as CA
crosslinked partners in immature and mature M-MuLV
particles, respectively. These proteins may represent cel-
lular factors that actively participate in the M-MuLV rep-
lication cycle.
RESULTS
Assembly of immature and mature virus particles
To study M-MuLV virus particle assembly and struc-
ture, we have employed a COS cell-based transient
transfection system. The vectors used for transfection
were based on the parental construct pXM, which carriesa simian virus 40 (SV40) origin of replication that allows
replication of the plasmid in COS cells, and the adeno-
virus major late promoter, which fosters high levels of
transcription initiation in COS cells. Our parental PR2
construct (pXM2453) deletes M-MuLV pol and env re-
gions and directs the expression of immature virus par-
ticles (Hansen and Barklis, 1995). Our wild-type (wt) con-
struct (pXMGPE) expresses all three M-MuLV genes
(gag, pol, and env) and directs expression of mature
M-MuLV particles. Two other parental constructs were
employed routinely. These were PR2Cys2, which assem-
bles immature virions in which all five gag cysteine
codons were converted to serines (Fig. 1; Hansen and
Barklis, 1995), and MA1CACys2, a PR1 (pXMGPE) vari-
ant in which the MA and CA cysteine codons (Fig. 1)
have been converted to serines. Other pertinent muta-
tions were cysteine creation mutations near the N-termi-
nus of the CA domain (G220C), near the CA C-terminus
(S475C), and at the N/B determining region (T323C) and
a previously studied MHR double mutation, E370C/
K373C (Hansen and Barklis, 1995; see Fig. 1). The double
mutation was expressed on a PR2Cys2 background to
yield PR2Cys2 E370C/K373C, while the G220C, S475C,
and T323C mutations were expressed in both PR2Cys2
and MA1CACys2 (but PR1) contexts, giving PR2Cys2G220C,
R2Cys2S475C, PR2Cys2T323C, MA1CACys2G220C,
MA1CACys2S475C, and MA1CACys2T323C.
For assembly analysis, cell lysate and pelleted media
supernatant samples were collected 3 days posttrans-
fection, and gag-derived proteins were separated by
SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
and detected by immunoblotting (see Materials and
Methods). As can be seen from Fig. 2A, all PR2 con-
tructs were released efficiently from cells as indicated
y comparison of Pr65Gag levels in the viral supernatants
Fig. 2A, lanes A–F) versus cell lysates (Fig. 2A, lanes
–M). The PR1 constructs also directed the efficient
release of Gag proteins from cells. As expected (Fig.
2B), wt, MA1CACys2S475C, MA1CACys2T323C, and
MA1CACys2G220C Pr65Gag and CA proteins were de-
ected readily in media samples (Fig. 2A, lanes A–D),
hile only Pr65Gag proteins were observed in cell
amples (Fig. 2A, lanes F–I). Note that for the
A1CACys2S475C mutant, a gag-derived 40-kDa media
band was observed (Fig. 2A, lane B) about 80% of the
time with the anti-CA antibodies, Hy187, and the poly-
clonal anti-CA. Since this band was not observed with
the anti-p12 antibody Hy548 in virus particles (data not
shown) it may represent an incomplete CA–NC cleavage
product. That media supernatant Gag proteins were par-
ticle-associated was suggested by the fact that they
sedimented through sucrose cushions at clearing rates
consistent with sedimentation coefficients of .120S and
with densities of 1.15–1.18 g/ml (Hansen and Barklis,
1995; data not shown), as expected for virus particles.
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192 MCDERMOTT ET AL.Crosslinking analysis of immature virus particles
To test the proximity of CA domain cysteine residues in
PrGag proteins in immature M-MuLV virus particles we
tilized our established crosslinking protocol (Hansen
nd Barklis, 1995; McDermott et al., 1996). Briefly, unique
cysteine residues on adjacent molecules will not form
covalent crosslinks if the cysteine residues are sepa-
rated by too great a distance, when treated with mem-
brane-permeable, cysteine-specific crosslinking agents
such as molecular iodine (maximum crosslinking dis-
FIG. 1. Schematic diagram of M-MuLV Pr65Gag protein. The M-MuLV P
ines), and nucleocapsid (NC), that are cleaved by the viral protease (P
ength and the juncture codons are indicated. The five natural cysteine
op bar with their respective gag codon numbers. Within the capsid d
HR includes codons 357 to 378. Antibody epitopes for hybridoma 548
he polyclonal anti-CA antibody, which binds to the capsid domain, are i
mutations were constructed on a PR2Cys2 parent (gray box). In contras
(MA1CACys2) but retained all NC cysteines (black box). The parental
are represented schematically with an X denoting a naturally occur
designation) representing a cysteine creation. Specific cysteine creat
indicates the wt residue, the number corresponds to the gag codon nu
Gray or black boxes associated with each construct denote whether th
oth.tance approximately 5 Å) or BMH (maximum crosslinking
distance approximately 15 Å). In contrast, adjacent mol-
i
Pecules with cysteines in close proximity may form cova-
lent crosslinks that can be detected after gel electro-
phoresis and immunoblotting. As shown in Fig. 3, when
PR2 virions lacking both pol and env gene products were
ock-treated, the expected Pr65Gag band was detected
ith anti-p12 antibodies (Fig. 3, lane F). However, a
arallel crosslinked sample (Fig. 3, lane E) gave the
5-kDa band plus a 130-kDa dimer product, consistent
ith previous observations (Hansen and Barklis, 1995),
emonstrating Pr65Gag crosslinking via NC cysteine res-
protein consists of four domains, matrix (MA), p12, capsid (CA, stippled
ing the budding process. The precursor polypeptide is 538 codons in
65Gag and the five introduced cysteine mutations are indicated on the
the N/B tropism determination site is at codons 324 and 325 and the
binds the p12 domain, hybridoma 187, which binds near the MHR, and
d at the top. Note that the parental immature construct is PR2 and that
ature parent construct eliminated matrix and capsid domain cysteines
re and mature constructs as well as the individual cysteine mutations
steine that has been removed and a C (preceded by the mutation
tations use a letter-number-letter nomenclature, where the first letter
nd the second letter indicates the newly created amino acid residue.
ine creation was expressed in a PR2Cys2 or MA1CACys2 context orr65Gag
R) dur
s in Pr
omain,
, which
ndicate
t, the m
immatu
ring cy
ion mu
mber, adues. As expected, crosslinking treatment of the
R2Cys2 mutant particles showed only a trace of a band
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193MURINE LEUKEMIA VIRUS CAPSID PROTEINat 130 kDa (Fig. 3, lane C; discussed below), consistent
with the specificity of BMH for preferential crosslinking at
cysteine residues. Results from crosslinking treatments
of PR2Cys2E370C/K373C particles also agreed with pre-
ious results, showing no dimer band, but instead a
rosslinked product at about 190 kDa (Fig. 3, lane A).
either the N-terminal PR2Cys2G220C nor the
R2Cys2T323C mutant particles gave Pr65Gag dimer
bands upon crosslinking (Fig. 3, lanes I and K), but each
showed crosslinked bands at 190 kDa, similar to that
seen for PR2Cys2E370C/K373C. In contrast, crosslinking
of PR2Cys2S475C particles, which carry single Pr65Gag
cysteines near the C-terminus of the CA domain, gave a
band that comigrates with Pr65Gag dimers (Fig. 3, lane G),
uggesting that C-terminal CA domains are in close
roximity in immature M-MuLV virions.
Although the results shown in Fig. 3 were observed in
lmost all experiments, it is important to point out that
xperiment-to-experiment variations were observed.
hile PR2 showed Pr65Gag crosslinked dimers in 18 of 18
experiments with three different antibodies (Table 1), it
also showed evidence of a 190-kDa band at least once.
As noted above, a faint dimer band was seen on BMH
treatment of PR2Cys2 particles (Fig. 3, lane C). Faint
imers were observed in 36% of our experiments using
FIG. 2. Expression and release of mutant Gag proteins. (A) As
described under Materials and Methods, virus particle (lanes A–F) and
cell lysate (lanes H–M) samples were collected from cells trans-
fected with the following PR2 pXM2453 vectors: wt PR2 (lanes A, H),
R2Cys2 (B, I), PR2Cys2E370C/K373C (C, J), PR2Cys2G220C (D, K),
PR2Cys2S475C (E, L), PR2Cys2T323C (F, M). Samples were subjected
o SDS–PAGE and electroblotted, and Gag proteins were detected with
he anti-p12 antibody Hy548. The protein size standard (faint) is in lane
, and the Pr65Gag band is indicated. (B) Virus particle (lanes A–D)
nd cell lysate (lanes F–I) samples were collected from cells trans-
ected with the following pXMGPE (PR1) vectors: wt (lanes A, F),
MA1CACys2S475C (B, G), MA1CACys2T323C (C, H), MA1CACys2G220C
(D, I). Samples were fractionated and immunoblotted as above, except
the anti-CA antibody Hy187 was employed. The protein size standard
appears faintly in lane E, and Pr65Gag and CA proteins are as indicated.wo different antibodies: we assume that such dimers
esulted from maleimide side reaction with histidinesnd primary amine groups, which can occur at low levels
t pH 7.4–7.5 (Smyth et al., 1964). We also observed some
rosslinking variability with PR2Cys2G220C, PR2Cys2T323C,
R2Cys2E370C/K373C, and PR2Cys2S475C particles
Table 1). However, the general conclusions of Fig. 3
ere supported in multiple experiments. Specifically,
he PR2Cys2S475C mutant proteins showed 130-kDa
bands 91% of the time, while the PR2Cys2G220C,
R2Cys2T323C, and PR2Cys2E370C/K373C mutants
gave 190-kDa bands 93, 82, and 100% of the time, re-
spectively. A crosslinked band of this size could repre-
sent a Gag protein crosslinked to a cellular protein or,
alternatively, a crosslinked Gag trimer, which seems un-
likely since the band is observed with mutant Gag pro-
teins containing only one cysteine residue.
Crosslinking analysis of mature virus particles
For crosslinking studies on mature virus particles, we
employed a parental MA1CA cysteine to serine con-
struct (MA1CACys2), which does not block proteolytic
processing. The experimental methods used for
crosslinking analysis of mature virus particles followed
those used for the immature virus particles (see above).
As shown in Fig. 4, proteins from MA1CACys2 particles
showed only Pr65Gag and CA bands but no crosslinked
ands (Fig. 4, lanes A and B) as expected. With mock-
reated MA1CACys2G220C a 58-kDa band was ob-
served in addition to the Pr65Gag and CA bands (Fig. 4,
FIG. 3. Crosslinking of M-MuLV protease-minus Gag proteins. Im-
mature virus particles produced by constructs PR2Cys2E370C/K373C
lanes A, B), PR2Cys2 (C, D), PR2 (E, F), PR2Cys2S475C (G, H),
R2Cys2G220C (I, J), and PR2Cys2T323C (K, L) were mock-treated
(lanes B, D, F, H, J, and L) or treated with BMH (lanes A, C, E, G, I, and
K), as described under Materials and Methods, to crosslink neighbor-
ing cysteine residues. Samples were subjected to SDS–PAGE and
electroblotted, and Gag proteins were detected with the anti-p12 anti-
body Hy548. Pr65Gag proteins and the putative Pr65Gag homodimers are
indicated. The arrow denotes the putative heterodimer crosslinked
band for lanes A, I, and K.
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194 MCDERMOTT ET AL.lane C). Since this band also was detected with our
anti-p12 antibody (Hy548; Fig. 4, lane E) it is possible that
the band represents a processing intermediate and may
comprise the MA1p121CA domains. Notwithstanding
the putative processing intermediate, examination of the
crosslinked G220C sample showed an additional 60-kDa
band (Fig. 4, lane D), consistent with the creation of a
CA–CA crosslink dimer. As would be expected for a
strictly CA-derived moiety, the 60-kDa band was not
T
Observed Crosslinked
Construct Crosslinked band
PR2 PrGag dimer
PrGag tetramer
220 kDa
205 kDa
190 kDa
PR2Cys2 PrGag dimer (faint)
190 kDa
160 kDa
PR2Cys2E370C/K373C PrGag dimer
190 kDa
PR2Cys2G220C PrGag dimer
190 kDa
PR2Cys2S478C PrGag dimer
190 kDa
PR2Cys2T323C PrGag dimer
190 kDa
Note. Crosslinking reactions were performed as described under Ma
cells with the indicated constructs. Crosslinked bands are designated
crosslinked species. The designation of “faint” for PR2Cys2 PrGag dime
PrGag dimers. The total number of gels signifies the number of indepen
the total number of gels. The antibodies column indicates the differen
FIG. 4. Crosslinking of mature M-MuLV Gag proteins. Virus particle
(C–F), MA1CACys2S475C (G, H), and MA1CACys2T323C (I, J) were m
) as described under Materials and Methods. Protein samples were fr
ybridoma Hy187 (lanes A–D, G–J) or the anti-p12 hybridoma Hy548 (lanes E,
ragment p27 are indicated. Arrows in lanes D, H, and J indicate crosslinkeddetected with the anti-p12 antibody (Fig. 4, lane F), sup-
porting the notion that the band corresponds to a CA–CA
dimer. In the case of the MA1CACys2S475C mutant, we
observed the faint uncrosslinked 40-kDa band (Fig. 4,
lane G), which appears to correspond to a CA–NC pro-
cessing intermediate (as in Fig. 2). In Fig. 4, lane H, an
additional crosslinked band at 62 kDa was observed.
This 62-kDa band was not detected with the anti-p12
Hy548 antibody (data not shown), suggesting that it also
s for PR2 Constructs
e observed Total no. gels Antibodies
100 18 187, 548, CA
17 18 187, 548, CA
6 18 548
6 18 548
6 18 548
36 14 548, CA
14 14 548
7 14 CA
7 14 CA
93 14 548, CA
9 11 548
82 11 187, 548
91 11 187, 548
9 11 548
0 8 548
100 8 548
and Methods on immature virus particles produced on transfection of
tative PrGag dimers or tetramers or as apparent molecular masses of
ates that bands were detectable, but at levels less than 10–25% of wt
osslinking experiments; the percentage of time observed is based on
dies that have been used to detect a specific crosslinked band.
cells transfected with pXMGPE (wild type; A, B), MA1CACys2G220C
ated (lanes A, C, E, G, and I) or treated with BMH (lanes B, D, F, H, and
ted by SDS–PAGE, electroblotted, and then detected with the anti-CAABLE 1
Band
% tim
terials
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ock-tre
actionaF). Bands corresponding to Pr65Gag, CA, and the proteolytic MA1p12
bands.
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195MURINE LEUKEMIA VIRUS CAPSID PROTEINrepresents a CA–CA dimer, which migrates slightly dif-
ferently than the apparent G220C CA–CA dimer, possibly
because of its different crosslinking site. While the
MA1CACys2G220C and S475C variants showed puta-
ive CA crosslinked dimer bands, the MA1CACys2T323C
crosslinking pattern was quite different. As shown (Fig. 4,
lane J), a faint 60-kDa dimer may be evident, but the
prominent crosslinked bands migrated at 75 and 80 kDa
(arrows).
As with the PR2 crosslinking results (Fig. 3; Table 1),
although the crosslinking results with mature virus par-
ticles were generally reproducible, some variability
was observed (Table 2). Nevertheless, with the
MA1CACys2G220C mutant, the 60-kDa putative dimer
and was observed nearly 90% of the time. While less
onsistent, the putative MA1CACys2S475C CA dimers
were observed nearly two-thirds of the time, and
MA1CACys2T323C 75- to 80-kDa bands were seen in
hree-quarters of the experiments. In contrast, with the wt
onstruct, 60-, 62-, 75-, and 80-kDa bands were observed
ess than 10% of the time (Table 2).
Both the 75- and the 80-kDa crosslinked bands were
bserved after iodine-mediated crosslinking (data not
hown), supporting the notion that interacting cysteines
ere close enough to form disulfides. During follow-up
tudies with reducible cysteine-specific crosslinking
gents, we found that formation of reducible Gag protein
T
Observed Crosslinked
Construct Crosslinked band
wt PrGag dimer
60 kDa
62 kDa
37 kDa
MA1CACys2G220C PrGag dimer
60 kDa
75 kDa
40 kDa
MA1CACys2S478C PrGag dimer
62 kDa
60 kDa
45 kDa
75 kDa
40 kDa
37 kDa
MA1CACys2T323C PrGag dimer
80 kDa
75 kDa
60 kDa
50 kDa
Note. Crosslinking reactions were performed as described under Mat
ith the indicated constructs. Crosslinked bands are designated as puta
he total number of gels signifies the number of independent crosslink
f gels. The antibodies column indicates the different antibodies thatrosslinks could be induced simply by particle treatment
ith dimethyl sulfoxide (DMSO), which often is used toolubilize membrane-permeant crosslinking agents. The
rosslinking potential of DMSO has been reported pre-
iously (Tam et al., 1991) and is consistent with reports of
its oxidizing capabilities. To ascertain DMSO crosslink-
ing effects on mature virions, particles were treated with
DMSO and then either reduced (Fig. 5, lanes A to D) or
not reduced (Fig. 5, lanes E to H), fractionated by SDS–
PAGE, and immunoblotted to detect Gag proteins. For wt
M-MuLV mature virus particles, no crosslinking was de-
tected with DMSO (compare Fig. 5, lanes A and E), as
expected from BMH results (Fig. 4) and indicating that
s for PR1 Constructs
observed Total no. gels Antibodies
40 25 187, 548, CA
8 25 187
4 25 187
4 25 187
15 27 187, 548, CA
89 27 187, CA
4 27 187
4 27 187
9 22 187, 548
64 22 187
27 22 187
18 22 187
9 22 187
9 22 187
5 22 187
4 25 187
76 25 187
76 25 187
24 25 187
4 25 187
nd Methods on mature virus particles produced on transfection of cells
Gag dimers and as apparent molecular masses of crosslinked species.
eriments; the percentage time observed is based on the total number
en used to detect a specific crosslinked band.
FIG. 5. DMSO-induced crosslinking of mature virus particle proteins.
Virus particles from cells transfected with pXMGPE (wild type; A, E),
MA1CACys2G220C (B, F), MA1CACys2T323C (C, G), and
A1CACys2S475C (D, H) were treated with DMSO as described under
Materials and Methods. Protein samples were separated on a reducing
gel (lanes A–D) or a nonreducing gel (lanes E–H), after which electro-
blotted Gag proteins were detected using the anti-CA antibody Hy187.
Bands representing the Pr65Gag and mature CA proteins are indicated,ABLE 2
Band
% time
erials a
tive Pras are the locations of the crosslinked products for each mutant at the
right.
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196 MCDERMOTT ET AL.the natural capsid cysteine residues (C270; Fig. 1) are
not in close proximity on neighbor molecules. In contrast
to the wt results, but in concert with comparable BMH
results (Fig. 4), MA1CACys2G220C proteins showed the
utative CA dimer band at 60 kDa (Fig. 5, lane F) and
utative 62-kDa MA1CACys2S475C dimer bands were
lso observed (Fig. 5, lane H). Furthermore, one CA
rosslinked band was present at 75–80 kDa in the
reated MA1CACys2T323C mutant lane (Fig. 5, lane G),
consistent with the appearance of a single 80-kDa
crosslinked product or the comigration of the 75- and
80-kDa species seen in Fig. 4. From these data it ap-
pears that MA1CACys2G220C, T323C, and S475C
rosslinking partners are within 5 Å of one another. Since
MH samples were run under reducing conditions (Figs.
and 4), it also would appear that BMH reacts with
ysteines more quickly than its solvent, DMSO, or that
MSO-induced disulfides can exchange with BMH to
orm nonreducible crosslinks.
Based on the size of the MA1CACys2T323C cross-
inked bands and amounts of Pr65Gag present in virus
particle preparations, it was possible that the 75- to
80-kDa bands could represent fast-migrating cross-
linked Pr65Gag-CA species. To test this hypothesis,
MA1CACys2T323C controls (Fig. 6, lanes B–D and F–G)
nd BMH crosslinked samples (Fig. 6, lanes A and E)
ere electrophoresed and blotted in parallel with anti-CA
ntibody (Hy187; Fig. 6, lanes A–D) or with anti-p12 an-
ibody (Hy548; Fig. 6, lanes E–H). The 75- and 80-kDa
ands were detected with the anti-CA antibody but not
FIG. 6. Composition of the MA1CACys2T323C crosslinked band.
Virus particles from cells transfected with MA1CACys2T323C were
ither BMH-treated (A, E) or mock-treated (B–D, F–H), after which
rotein samples were fractionated on a reducing SDS–PAGE gel. After
lectrophoresis, samples were electroblotted and then immunoblotted
sing either the anti-CA antibody, Hy187 (lanes A–D), or the anti-p12
ntibody, Hy548 (lanes E–H). Indicated are Pr65Gag, CA, and the pro-
eolytic MA1p12 fragment, p27. Arrows indicate the 75- and 80-kDa
rosslinked bands.he anti-p12 antibody (Fig. 6, lane A versus lane E),
ndicating that the 75- and 80-kDa bands were not de-ived from Pr65Gag crosslinks. We also performed parallel
crosslinking immunoblots with anti-actin, anti-tubulin,
and anti-PDI (protein disulfide isomerase) antibodies.
These experiments were performed because HIV-1 Gag
proteins have been shown to interact with cytoskeletal
proteins (Ott et al., 1996; Perrin-Tricaud et al., 1999; Rey et
al., 1996; Wilk et al., 1999), while PDI, which catalyzes
protein disulfide formation and exchange, could be pos-
tulated to associate with cysteine residues on mutant
proteins. Nevertheless, actin, tubulin, and PDI antibodies
did not bind to the 75- to 80-kDa MA1CACys2T323C
crosslinked bands (data not shown), suggesting the ex-
istence of alternate crosslinked partners in these virions.
DISCUSSION
In this paper, we describe the crosslinking analysis of
M-MuLV capsid proteins in mature and immature virus
particles. These experiments were undertaken to com-
plement structural models derived from in vitro studies.
Although previous crosslinking studies have been em-
ployed successfully to examine viral protein interactions
(Pepinsky, 1983; Pepinsky et al., 1980; Pinter and Fleiss-
ner, 1979), we chose the cysteine crosslinking approach
to avoid complications in interpretation arising from us-
ing amine-specific crosslinking agents, which can react
with a large number of residues present in M-MuLV Gag.
Nevertheless, as with other crosslinking methods, the
composition of crosslinked bands has been inferred from
gel mobilities, and interpretations must be considered
with this caveat in mind. Because our approach requires
making mutations on PR2Cys2 and MA1CACys2 paren-
al constructs, some results may not be pertinent wt
onstructs. Additionally, the PR2 construct does not ex-
ress pol and env gene products, an alteration that may
isrupt the internal structure of immature virions. Since
e have not performed electron microscope analyses of
irus particles produced from transiently transfected
ells, we do not know whether some mutants might
how morphologies that are visibly different from their wt
ounterparts. However, the PR2Cys2 and MA1CACys2
Gag proteins directed the efficient assembly of particles
with apparently normal masses and densities (Fig. 2;
Hansen and Barklis, 1995; data not shown), and the
approach has been used previously to examine retrovi-
rus particle structures (Hansen and Barklis, 1995; Mc-
Dermott et al., 1996). Thus, we believe that our results
are relevant to the analysis of immature and mature
M-MuLV particles.
Our studies show that particle-associated wt PR2 Gag
proteins can be crosslinked to form dimers (Fig. 3). This
finding is consistent with our previous observations that
PrGag proteins in immature virions crosslink via the NC
zinc finger cysteines (Hansen and Barklis, 1995) and
agrees with the previous results showing that NC cys-
teines are targets for thiol reactive compounds (Ott et al.,
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197MURINE LEUKEMIA VIRUS CAPSID PROTEIN1998; Rein et al., 1996, 1997). We also observed that
R2Cys2S475C proteins could be crosslinked to form
imers, suggesting that CA C-terminal domains are
losely associated in immature virions. In contrast,
r65Gag dimers were not observed with the
PR2Cys2G220C, T323C, or E370C/K373C mutants (Fig.
). Instead crosslinked bands from these mutants mi-
rated with apparent mobilities of 185–190 kDa on 7.5%
els, similar to our previous observations for the
R2Cys2E370C/K373C mutant (Hansen and Barklis,
995), as well as for the other major homology region
utants PR2Cys2L369C and PR2Cys2E370C (Hansen
nd Barklis, 1995). The observed 190-kDa band is ap-
roximately the size of three covalently linked PrGag
monomers, but is seen with mutants containing only one
cysteine residue. This consideration is consistent with
the crosslinking partner being a cellular protein or with
anomalous crosslinking of PrGag monomers to form trim-
ers. We are attempting to generate a sufficient quantity of
the 190-kDa band to characterize this complex further.
Relative to immature virions, CA proteins in mature
M-MuLV particles showed different crosslinking reactiv-
ities. While the natural CA C270 residues did not mediate
dimer formation in mature virions (Fig. 4), BMH (Fig. 4),
iodine (data not shown), and DMSO (Fig. 5) treatments
yielded both MA1CACys2G220C and S475C 60- to 62-
Da crosslinked bands, which appear to correspond to
A–CA dimers. Assuming that the 60- to 62-kDa bands
epresent bona fide CA dimers, our results suggest that
uring maturation, capsid protein interactions reorganize
o permit dimer formation at both N- and C-termini. This
s consistent with the maturational conformation model
roposed for HIV-1 in which constrained PrGag CA N-
termini refold during proteolytic processing (Schwedler
et al., 1998) and previous crosslinking results in M-MuLV
(Pepinsky, 1983) and in avian sarcoma and leukemia
viruses (Pepinsky et al., 1980). Structural studies on HIV-1
and EIAV have shown that these capsid proteins crystal-
lize as dimers (Gamble et al., 1997; Jin et al., 1999;
Momany et al., 1996) with higher order interactions form-
ing the supermolecular particle structure. Our data sup-
port the idea that multiple and distant regions of the
M-MuLV capsid domain participate in close interprotein
contacts in both the immature and the mature virus
particle structures.
In contrast to results with MA1CACys2G220C and
475C, the 75- to 80-kDa T323C crosslinked products do
ot appear to be simple CA dimers. Our evidence sug-
ests that the 75- to 80-kDa bands contain a CA moiety,
ut do not appear to be composed of p12-containing
rGag molecules (Fig. 6). Conceivably, these bands could
represent anomalously migrating CA trimer bands, but
crosslinked trimers are unexpected for monomers, which
carry only single cysteines. Based on parallel immuno-
2blot analysis, the MA1CACys T323C crosslinked part-
ners do not appear to be actin, tubulin, or PDI. Further-
b
cmore the 75- to 80-kDa products would seem to be too
small to include env gene product, gp70, or viral reverse
transcriptase proteins. It is intriguing to speculate
whether the MA1CACys2T323C crosslinked partner
ould be involved in the Fv1 host-range restriction phe-
omenon. In this regard, it is of interest that the predicted
ize of the Fv1 N/B-related murine host factor is about 52
Da and appears to correspond to a murine homolog of
he gag gene of the human endogenous retrovirus,
ERV-L (Best et al., 1996). However, while the 75- to
80-kDa MA1CACys2T323C crosslinked products sug-
est that crosslinked partners are present at reasonably
igh levels in virus particles produced from African green
onkey (COS) cells, the Fv1 gene product appears to
xert its effects in target murine cells, despite very low
evels of expression (Best et al., 1996). Consequently, for
he present it is not clear how or if the
A1CACys2T323C crosslinked partners relate to Fv1
restriction.
MATERIALS AND METHODS
Constructs
The M-MuLV transient expression vector was derived
from pXM (Yang et al., 1986), which uses an SV40 origin
of replication and adenovirus major late promoter. Con-
struction and sequencing of mutant vectors followed
standard protocols (Maniatis et al., 1982). M-MuLV was
odified by the addition of 59 EcoRI and EcoRV sites
(GAATTCGATATCAAGCTT) at the HindIII site [M-MuLV nt
563 (Shinnick et al., 1981)] of pMov-Psi (Mann et al., 1983)
nd used to create pXMGPE, which spans M-MuLV nt
66 to 7846 and expresses M-MuLV gag, pol, and env
ene products. The PR2 transient expression vector
XM2453 encodes M-MuLV viral nt 566–2453 and has a
ermination signal downstream of nt 2453 and thus lacks
oth the pol and the env genes. Downstream junction
equences for both constructs are as follows: pXMGPE,
9 TTTGGCAAGCTAGA 39, in which nt 7840 from the 39
untranslated sequence is underlined; pXM2453, 59 GGT
AG GTC ACC GCG GAT CCC CCT TAA GTT AAC TTA
AGG GCT GCA GGA ATT C 39, in which nt 2453 is
underlined and the termination codon is in boldface type.
As previously described (Hansen and Barklis, 1995),
pXMGPE and pXM2453 were used as PR1 and PR2
templates for the introduction of cysteine-to-serine point
mutations. All five cysteine-to-serine point mutations, in-
cluding C504S/C507S, previously described (Gorelick et
al., 1988), were cloned into the two parental vectors to
yield a pXM2453 all cysteine-to-serine construct
(pXM2453Cys2 or PR2Cys2) and a pXMGPE all cysteine-
o-serine construct (pXMGPECys2 or wtCys2). The se-
uences of these cysteine mutants, with the first nucle-
tide of the sequence listed, the modified nucleotides in
oldface type, and the codons where an amino acid was
hanged underlined, are as follows: C39S (nt 723), 59
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198 MCDERMOTT ET AL.TGG GTT ACG TTC TCC TCT GCA 39; C270S (nt 1419), 59
TGG GAC GAT AGT CAA CAG 39; C504S/C507S (nt 2123),
59 GAC CAG TCT GCC TAC TCC AAA 39; and C517S (nt
2163), 59 AAA GAT TCT CCC AAG AAG CCT CGA 39. In
addition to the pXMGPE Cys2 construct, we constructed
pXMGPE capsid cysteine-to-serine construct (pXMG-
ECACys2 or CACys2), which contains only the C270S
mutation. Additionally, a pXMGPE matrix plus capsid
cysteine-to-serine construct (pXMGPEMA1CACys2 or
A1CACys2), which contains the C39S and C270S mu-
ations, was also made.
With regard to cysteine creation mutants,
R2Cys2E370C/K373C, has been described (Hansen
nd Barklis, 1995). It introduces two cysteine residues in
he MHR region (E370C/K373C [nt 1722], 59 TTC CTA TGT
CGA CTT TGC GAA GCC TAT CGC ACG TAC ACT CCA
TAT 39). In addition to this cysteine creation mutant,
several others were made in the capsid domain: G220C
(shown from nt 1266), 59 CCC CTC CGC GCA TGC GGA
AAC GGA 39; T323C (shown from nt 1566), 59 CGC CCA
AC AGG GAT TAC ACA TGT CCC AGG 39; and S475C
(shown from nt 2031), 59 CAT AGA GAG ATG TGT AAG
CTA TTG GCC 39. These mutants were introduced into
the parental constructs PR2Cys2, CACys2, and
A1CACys2.
ell culture and viruses
COS1 and COS7 cells were maintained in Dulbecco’s
odified Eagle’s medium (DMEM) supplemented with
0% heat-inactivated fetal calf serum, penicillin, and
treptomycin. Cells were split 1:4 from confluent plates
nto 10-cm-diameter plates 24 h prior to transfections
nd were transfected with 16 mg plasmid DNA by the
calcium phosphate precipitation method (Hansen and
Barklis, 1995). Three days posttransfection, cell lysates
and supernatants were collected as previously de-
scribed (Hansen and Barklis, 1995). Cell-free superna-
tants from transfected cells were centrifuged through
4-ml 20% sucrose cushions at 83,000 g (25,000 rpm in an
SW28 rotor) for 2 h at 4°C. Virus pellets were resus-
pended in phosphate-buffered saline [PBS; 9.5 mM so-
dium potassium phosphate (pH 7.4), 137 mM NaCl, 2.7
mM KCl]. Cells were rinsed twice with PBS, collected in
IPB [20 mM Tris–hydrochloride (pH 7.5), 150 mM NaCl, 1
mM EDTA, 0.1% SDS, 0.5% sodium deoxycholate, 1%
Triton X-100, 0.02% sodium azide], vortexed for 1 min, and
centrifuged (13,700 g, 4°C, 10 min) to remove insoluble
material. For protein gels, solubilized cellular lysates
were mixed with equal volumes of 23 sample buffer
[12.5 mM Tris–hydrochloride (pH 6.8), 2% SDS, 20% glyc-
erol, 0.25% bromophenol blue] plus 5% b-mercaptoetha-
nol (b-Me).
Sucrose density gradient fractionation of virus parti-
les was performed as previously described (Hansen
nd Barklis, 1995; McDermott et al., 1996). Briefly, extra-
1cellular virions were isolated by pelleting through su-
crose cushions as described above, after which they
were applied to sucrose gradients consisting of 1.1-ml
layers of 20, 30, 40, and 50% sucrose that had been
allowed to mix by sitting for 1 h at 4°C. Gradients were
centrifuged at 300,000 g (50,000 rpm in an SW50.1 rotor)
overnight at 4°C and 400-ml fractions were collected
from top to bottom for analysis by immunoblotting as
described below.
Protein and crosslinking analysis
Protein samples were analyzed by SDS–PAGE
(Laemmli, 1970). Unless otherwise stated, electrophore-
sis was performed using 7.5 or 10% SDS–PAGE gels.
Electrophoresis ordinarily was performed under reduc-
ing conditions, which were achieved by the addition of
an equal volume of 23 sample buffer plus 5% b-Me (v/v
inal) to the protein samples. For nonreducing condi-
ions, b-Me was omitted. After electrophoresis under
standard conditions (Hansen et al., 1990, 1993; Hansen
and Barklis, 1995; Jones et al., 1990; Laemmli, 1970;
McDermott et al., 1996), gels were electroblotted onto
nitrocellulose filters and proteins were detected using
the Western blot procedure previously described (Han-
sen and Barklis, 1995). For size estimates, mobilities
were plotted versus log molecular weights of known size
standards. For immunoblotting, primary antibodies used
were rat monoclonal antibody hybridoma cell superna-
tants anti-M-MuLV p12Gag (Hy548) and anti-M-MuLV
p30Gag (Hy187) used at 1:10 dilutions (Chesebro et al.,
1983); polyclonal goat anti-M-MuLV p30Gag (National Can-
er Institute), used at a 1:4000 dilution; mouse monoclo-
al anti-actin antibody (Boehringer Mannheim) used at
:2000 dilution; mouse monoclonal anti-protein disulfide
somerase (PDI; Affinity Bioreagents, Inc.) used at a di-
ution of 1:2000, and mouse monoclonal anti-tubulin (Am-
rsham) used at a dilution of 1:200. Secondary alkaline
hosphatase-conjugated antibodies were goat anti-
ouse immunoglobulin G (IgG; Promega) used at a
:20,000 dilution and rabbit anti-goat IgG (Boehringer
annheim), used at a 1:10,000 dilution.
Iodine crosslinking of cysteine residues was per-
ormed as previously described (Hansen et al., 1993;
Pakula and Simon, 1992) and analyzed by nonreducing
SDS–PAGE. For cross-linking with BMH (Pierce), BMH
was prepared fresh as a 100 mM solution in DMSO
(Mallinckrodt). Viral samples were split into equivalent
100-ml fractions, treated with BMH (1 ml of 100 mM BMH
in DMSO) or mock-treated (1 ml of DMSO), vortexed
gently, and incubated at room temperature for 1 h. Re-
actions were terminated by the addition of 23 sample
buffer plus b-Me to 5%, and the samples were boiled for
–5 min. For DMSO oxidation treatments (Tam et al.,
991), 1 ml of DMSO was added to each 100-ml tube,
vortexed gently, and incubated at room temperature. Reac-
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199MURINE LEUKEMIA VIRUS CAPSID PROTEINtions were terminated by the addition of 23 sample buffer
without B-Me followed by sample boiling for 3–5 min.
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